ANNE HOPKINS: Open Payments
NPI 1487354080 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 48 payments from 22 companies in 2025. Trend: 2023 $968 · 2024 $1,163 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $253 |
| Janssen Biotech, Inc. | 6 | $146 |
| GENZYME CORPORATION | 4 | $106 |
| Eisai Inc. | 1 | $85 |
| Daiichi Sankyo Inc. | 4 | $83 |
| PFIZER INC. | 3 | $68 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Ethicon US, LLC | 1 | $35 |
Products named: CABLIVI, RYBREVANT, ENHERTU, OJJAARA, KEYTRUDA, IBRANCE, Nubeqa, DATROWAY.
Industry payments across GA — which companies pay providers there.
